JP2003169631A - Anti-allergic drink or food - Google Patents

Anti-allergic drink or food

Info

Publication number
JP2003169631A
JP2003169631A JP2001374099A JP2001374099A JP2003169631A JP 2003169631 A JP2003169631 A JP 2003169631A JP 2001374099 A JP2001374099 A JP 2001374099A JP 2001374099 A JP2001374099 A JP 2001374099A JP 2003169631 A JP2003169631 A JP 2003169631A
Authority
JP
Japan
Prior art keywords
extract
hesperidin
allergic
food
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001374099A
Other languages
Japanese (ja)
Other versions
JP4524465B2 (en
Inventor
Yukio Kadooka
幸男 門岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Snow Brand Milk Products Co Ltd
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Priority to JP2001374099A priority Critical patent/JP4524465B2/en
Publication of JP2003169631A publication Critical patent/JP2003169631A/en
Application granted granted Critical
Publication of JP4524465B2 publication Critical patent/JP4524465B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide an anti-allergic dink or food which can effectively reduce allergic syndromes. <P>SOLUTION: This effective anti-allergic drink or food simultaneously contains a chemical mediator release-inhibiting ingredient such as a Rubus suavissims S. Lee extract, a rose flowers extract, an apple extract, or a perilla extract and hesperitin known to inhibit the permeability of capillary vessel. <P>COPYRIGHT: (C)2003,JPO

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、アレルギー症状を
効果的に軽減させることのできる抗アレルギー用飲食品
に関する。
TECHNICAL FIELD The present invention relates to an antiallergic food and drink which can effectively reduce allergic symptoms.

【0002】[0002]

【従来の技術】アレルギー疾患は増加の一途をたどり、
今や、国民の3割が何らかのアレルギー症状を訴えるほ
どの深刻な問題となっている。代表的な症状としては、
花粉症、アレルギー性鼻炎、気管支喘息、アトピー性皮
膚炎等の症状が挙げられる。アレルギー疾患増加の要因
としては、食生活や住環境の変化、大気汚染、植林政
策、各種ストレスの増加、過剰な衛生志向等が指摘され
ており、現代病の一つと言うこともできる。
2. Description of the Related Art The number of allergic diseases is increasing,
Now, it is a serious problem that 30% of the people complain of allergic symptoms. Typical symptoms are
Examples include hay fever, allergic rhinitis, bronchial asthma, atopic dermatitis and the like. It has been pointed out that factors such as changes in eating habits and living environment, air pollution, afforestation policies, increase in various stresses, excessive hygiene and the like are factors that contribute to the increase in allergic diseases, and can be said to be one of modern diseases.

【0003】これらのアレルギー疾患は、多くの場合1
型アレルギー反応と呼ばれる反応によって引き起こされ
る。1型アレルギー反応は、抗原感作による特異的イム
ノグロブリンE(IgE)の産生、産生されたIgEのマスト
細胞との結合、マスト細胞結合IgEへの再侵入した抗原
の架橋、マスト細胞からのケミカルメディエーターの遊
離、遊離されたケミカルメディエーターによる毛細血管
の透過性増大および平滑筋収縮、という多段階のステッ
プを経て惹起される。そして、実際に起こる各種のアレ
ルギー症状とは、例えば鼻炎、喘息等では、毛細血管の
透過性増大に始まる炎症反応、あるいは喘息に代表され
る平滑筋収縮という反応によって代表される。
These allergic diseases are often
It is caused by a reaction called type-allergic reaction. Type 1 allergic reaction is the production of specific immunoglobulin E (IgE) by antigen sensitization, binding of produced IgE with mast cells, cross-linking of re-invaded antigen to mast cell-bound IgE, chemical reaction from mast cells. It is caused by a multi-step step of releasing mediators, increasing permeability of capillaries and contracting smooth muscle by the released chemical mediators. The various allergic symptoms that actually occur are represented by, for example, rhinitis, asthma, and the like, an inflammatory reaction that begins with an increase in capillary permeability, or a smooth muscle contraction that is represented by asthma.

【0004】なお、ケミカルメディエーターとは、炎症
反応に含まれる細胞間の情報伝達物質の総称であるが、
本発明においては、抗原の刺激によってマスト細胞や好
塩基球から遊離される、ヒスタミンに代表される化学物
質類のことを指す(生化学辞典第3版、東京化学同人、1
998)。アレルギー症状は、重篤な場合には医薬品等に
よって効果的に軽減させなければならない。
The chemical mediator is a general term for intercellular signaling substances included in inflammatory reactions.
In the present invention, it refers to chemical substances represented by histamine, which are released from mast cells and basophils by stimulation of antigens (Biochemical Dictionary 3rd Edition, Tokyo Kagaku Dojin, 1
998). In severe cases, allergic symptoms must be effectively reduced by medicines.

【0005】一方、食品由来の抗アレルギー成分にも大
きな関心が向けられている。古くから食されている食品
由来の成分は、その安全性が長い間の食経験により確か
められており、医薬品にしばしば見られるような副作用
を持つものが少ない。そのため、対症療法的な使用方法
のみならず、日常的な摂取による予防的な使用も可能と
なる。現在、抗アレルギー用食品とされているものは、
そのほとんどがマスト細胞からのケミカルメディエータ
ー遊離抑制作用を持つ成分が配合されているものであ
る。成分の代表的なものとしては、甜茶抽出物、バラ花
びら抽出物、リンゴ抽出物、シソ抽出物等がよく知られ
ている。ケミカルメディエーターが産生される経路につ
いても詳細に調べられており、2つの産生経路−シクロ
オキシゲナーゼ経路およびリポキシゲナーゼ経路−のあ
ることがわかっている。これらの経路に対する作用は抗
アレルギー成分によって異なり、例えば甜茶抽出物は前
者の経路を、シソ種子抽出物は後者の経路を抑制するこ
とが知られている。このことから、異なる抽出物を同時
に配合することによって、異なるケミカルメディエータ
ー産生経路を同時に抑制し、細胞からのケミカルメディ
エーター遊離を効率的に抑制する抗アレルギー用食品も
考案されている(特開平11-056297号公報)。
On the other hand, much attention has been paid to antiallergic ingredients derived from foods. The ingredients derived from foods that have been eaten for a long time have been confirmed to have safety by long-term eating experience, and few have side effects as often seen in pharmaceuticals. Therefore, not only the symptomatic use method but also the preventive use by daily intake becomes possible. What are currently considered foods for anti-allergies are:
Most of them contain a component having an action of suppressing chemical mediator release from mast cells. Well-known examples of the ingredients are beet extract, rose petal extract, apple extract, perilla extract and the like. The pathways by which chemical mediators are produced have also been investigated in detail, and it is known that there are two production pathways-a cyclooxygenase pathway and a lipoxygenase pathway. It is known that the action on these pathways differs depending on the anti-allergic component, and, for example, beetroot extract suppresses the former pathway and perilla seed extract suppresses the latter pathway. From this, antiallergic foods have been devised by simultaneously mixing different extracts to simultaneously suppress different chemical mediator production pathways and efficiently suppress the release of chemical mediators from cells (JP-A-11- No. 056297).

【0006】一方、アレルギーの発症は、すでに述べた
ように、IgEの産生、IgEのマスト細胞との結合、ケミカ
ルメディエーターの遊離、および遊離されたケミカルメ
ディエーターによる毛細血管の透過性増大あるいは平滑
筋収縮という一連の反応によって起こる。したがって、
実際のアレルギー症状を効果的に抑制するためには、ケ
ミカルメディエーター遊離の抑制だけでは十分とは言え
ない。
On the other hand, as described above, the onset of allergy is caused by the production of IgE, the binding of IgE to mast cells, the release of chemical mediators, and the increased permeability of capillaries or smooth muscle contraction by the released chemical mediators. It occurs by a series of reactions. Therefore,
In order to effectively suppress actual allergic symptoms, suppression of chemical mediator release alone is not sufficient.

【0007】[0007]

【発明が解決しようとする課題】以上のように、従来の
抗アレルギー用食品は、ケミカルメディエーターの遊離
を抑制する成分の配合にとどまっており、アレルギー症
状を引き起こす最も直接的なステップである毛細血管の
透過性増大を抑制する成分を配合したものはなかった。
本発明者らは、ケミカルメディエーターの遊離を抑制す
る成分に加えて、毛細血管の透過性を抑制することが知
られているヘスペリジンを同時に配合することで、実際
のアレルギー症状をより効果的に軽減させることを見出
した。従って本発明は、効果的な抗アレルギー用飲食品
を提供することを課題とする。
As described above, the conventional foods for anti-allergy are limited to the combination of the components that suppress the release of chemical mediators, and the most direct step that causes allergic symptoms is the capillary blood vessel. There was no formulation containing a component that suppresses the increase in the permeability of the.
The present inventors more effectively reduce actual allergic symptoms by simultaneously adding hesperidin, which is known to suppress capillary permeability, in addition to a component that suppresses release of chemical mediators. I found that. Therefore, an object of the present invention is to provide an effective antiallergic food and drink.

【0008】[0008]

【課題を解決するための手段】1型アレルギー反応の一
連のステップは既に説明した通りであるが、そのステッ
プの中で、どれか一つでも完全に抑制することができれ
ば、理論的にはアレルギー症状は起こらない。しかし、
通常、そのようなアレルギー発症までのステップを完全
に抑制することはきわめて難しく、1つのステップの抑
制のみでは現実的にはある程度の抑制効果しか示さな
い。特に、食品に医薬品のような強い作用を期待するこ
とは難しく、また、特定のステップに対する強い作用
は、副作用の可能性も考慮しなければならない。
[Means for Solving the Problems] The series of steps of type 1 allergic reaction is as described above, but if any one of them can be completely suppressed, theoretically allergic reaction can occur. No symptoms occur. But,
Usually, it is extremely difficult to completely suppress such steps leading to the onset of allergy, and the suppression of only one step practically shows only a certain suppressive effect. In particular, it is difficult to expect a strong effect on foods like a pharmaceutical, and the strong effect on a specific step must consider the possibility of side effects.

【0009】そこで、我々は、それぞれのステップに対
しては穏やかな抑制作用であっても、それらを組み合わ
せることでアレルギー症状を効果的に緩和させることが
できないかと考え、食品由来の成分を対象に様々な可能
性を鋭意検討した。その結果、ケミカルメディエーター
遊離を抑制する成分に加えて、ヘスペリジンを同時に配
合することで、アレルギー症状をより効果的に軽減させ
ることが可能であることを見出し、本発明を完成するに
至った。
[0009] Therefore, we wondered if combining them could effectively alleviate allergic symptoms, even if they had a mild inhibitory effect on each step, and targeted food-derived ingredients. We studied various possibilities. As a result, they have found that it is possible to more effectively reduce allergic symptoms by simultaneously blending hesperidin in addition to a component that suppresses chemical mediator release, and completed the present invention.

【0010】[0010]

【発明の実施の形態】本発明に使用するケミカルメディ
エーター遊離抑制物質としては、甜茶抽出物、バラ花び
ら抽出物、リンゴ抽出物等を挙げることができる。甜茶
抽出物は、中国広西壮族自治区に自生しているバラ科植
物Rubus suavissimus S. Leeの茶葉の熱水抽出物であ
り、サンテンチャ(登録商標)としてよく知られている。
ケミカルメディエーター遊離抑制の活性本体は、甜茶ポ
リフェノールであるエラジタンニンであることが解明さ
れている(平井、食品と開発、vol.32, p22-24, 199
7)。バラ花びら抽出物は、野生種バラ花びらの熱水抽
出物であり、ポリフェノールであるオイゲニインがケミ
カルメディエーター遊離抑制の活性本体であることが解
析されている(中川、食品工業、1999-2.28, p42-5
2)。リンゴ抽出物は、リンゴ未熟果より抽出精製され
たリンゴポリフェノール類含有画分である。リンゴ抽出
物のケミカルメディエーター遊離抑制作用は、主にリン
ゴ縮合型タンニンによるものであることが調べられてい
る(神田、食品と開発、vol.32, p28-30, 1997)。シソ
は古くから日本人に親しまれている植物であり、その抽
出物は様々な生理活性を有しており、シソ抽出物のマス
ト細胞からのケミカルメディエーター遊離抑制作用も知
られている(山崎、食の科学、2001.9, p10-16)。
BEST MODE FOR CARRYING OUT THE INVENTION Examples of the chemical mediator release inhibitor used in the present invention include beet extract, rose petal extract, apple extract and the like. The Chinese tea extract is a hot water extract of tea leaves of Rubus suavissimus S. Lee, a plant belonging to the family Rosaceae, which grows naturally in Guangxi, China, and is well known as Santencha (registered trademark).
The active substance that suppresses the release of chemical mediators has been elucidated to be ellagitannin, a tea polyphenol (Hirai, Foods and Development, vol.32, p22-24, 199).
7). The rose petal extract is a hot water extract of wild rose petals, and it has been analyzed that eugeniin, which is a polyphenol, is the active body of chemical mediator release suppression (Nakagawa, Food Industry, 1999-2.28, p42- Five
2). The apple extract is a fraction containing apple polyphenols extracted and purified from immature apple fruit. It has been investigated that the chemical mediator release inhibitory effect of apple extract is mainly due to apple condensed tannin (Kanda, Food and Development, vol.32, p28-30, 1997). Perilla is a plant that has been familiar to Japanese people since ancient times, and its extract has various physiological activities. It is also known that perilla extract suppresses the release of chemical mediators from mast cells (Yamazaki, Food Science, 2001.9, p10-16).

【0011】ヘスペリジンは、毛細血管の強化、透過性
増大の抑制、出血予防、血圧調整等の生理作用を有する
働きがあり、ビタミンPとも呼ばれる(日本ビタミン学
会、ビタミンハンドブック2−水溶性ビタミン、p195,
1989、化学同人)。また、このような働きは、ビタミン
Cと併用することでより効果的になる場合のあることも
知られている(島薗、万木、ビタミンII、p400-405, 19
80、共立出版;日本ビタミン学会、新ビタミン学、p439
-441, 1969、日本ビタミン学会)。
Hesperidin has a physiological action such as strengthening of capillaries, suppression of increase in permeability, prevention of bleeding, blood pressure regulation and the like, and is also called vitamin P (Vitamin Society of Japan, Vitamin Handbook 2-Water-soluble vitamin, p195). ,
1989, chemistry coterie). It is also known that such action may be more effective when used in combination with vitamin C (Shimazono, Mangi, Vitamin II, p400-405, 19).
80, Kyoritsu Shuppan; Japan Vitamin Society, New Vitaminology, p439
-441, 1969, The Vitamin Society of Japan).

【0012】本発明に使用するヘスペリジンとしては、
ヘスペリジンやヘスペリジンを多く含む抽出物、さらに
これらを糖転移酵素等により処理した酵素処理ヘスペリ
ジン等を挙げることができる。このようなヘスペリジン
として柑橘類の果汁や果皮から抽出したものを用いるこ
とができる。ヘスペリジンの供給源としては、レモン、
オレンジ、グレープフルーツ、ミカン、キンカン等食用
に供されるものから得られたものであれば使用可能であ
り、抽出精製されたヘスペリジンでもよいし、ヘスペリ
ジンを含むフラボノイド画分でもよい。ヘスペリジン
は、水への溶解性がきわめて低く、アルコールなどにも
ほとんど溶解しないが、糖転移酵素により処理すること
によって水溶性が高められる。飲料を製造する際、この
ような酵素処理ヘスペリジン(特開平3-7593号公報、特
開平10-70994号公報)を使用することが、本発明の実施
に当たってはより望ましい。これらの抽出物やヘスペリ
ジンは、いずれも長い間日常的に食されてきた食品に由
来するものであり、その安全性はきわめて高い。
As the hesperidin used in the present invention,
Examples thereof include hesperidin, an extract containing a large amount of hesperidin, and an enzyme-treated hesperidin obtained by treating these with a glycosyltransferase and the like. As such hesperidin, it is possible to use one extracted from citrus fruit juice or skin. As a source of hesperidin, lemon,
Any product obtained from food products such as orange, grapefruit, mandarin orange, and kumquat may be used, and hesperidin extracted and purified may be used, or a flavonoid fraction containing hesperidin may be used. Hesperidin has extremely low solubility in water and is hardly soluble in alcohol and the like, but its water solubility is enhanced by treatment with glycosyltransferase. It is more preferable to use such an enzyme-treated hesperidin (JP-A-3-7593 and JP-A-10-70994) in the production of a beverage in carrying out the present invention. These extracts and hesperidin are all derived from foods that have been eaten on a daily basis for a long time, and their safety is extremely high.

【0013】抗アレルギー用飲食品の形態としては、飲
料をはじめとして、飴、キャンディー、ガム等の固形食
品、クリーム状あるいはジャム状の半流動食品、ゼリー
等のゲル状食品等、食品として通常考えられる様々な形
態にすることが可能である。また、それぞれの配合量
は、一律に限定されるものではなく、製造される食品の
形態、風味、効果等を総合的に考慮して決定される。ケ
ミカルメディエーター遊離抑制物質は、前述の甜茶、バ
ラ花びら、リンゴ、シソを例にとると、1日あたりそれ
ぞれの抽出物の固形量換算で10〜1,000mg、ヘスペリジ
ン又は酵素処理ヘスペリジンは5〜500mg摂取すれば、抗
アレルギー効果が発揮されるので、この量が摂取できる
ように配合すればよい。
The form of foods and drinks for anti-allergy is usually considered as foods such as beverages, solid foods such as candy, candy and gum, semi-liquid foods like cream or jam, gel foods such as jelly. It is possible to have various forms. In addition, the amount of each compound is not limited to a uniform value, and is determined by comprehensively considering the form, flavor, effect, etc. of the food product produced. The chemical mediator release inhibitor is, for example, the above-mentioned beetle tea, rose petals, apples, and perilla, 10-1,000 mg of the solid amount of each extract per day, 5 to 500 mg of hesperidin or enzyme-treated hesperidin. If so, an anti-allergic effect is exerted, and therefore, it may be blended so that this amount can be ingested.

【0014】なお、ケミカルメディエーター遊離抑制物
質及びヘスペリジン又は酵素処理ヘスペリジンを飲料に
配合する場合には、飲料100mlで抗アレルギー効果を発
揮するように配合すると、アレルギー患者の治療や健康
管理を行う上で利便性が高い。例えば清涼飲料、お茶、
果汁飲料や乳飲料等に、ケミカルメディエーター遊離抑
制物質として前述の甜茶抽出物、バラ花びら抽出物、リ
ンゴ抽出物、シソ抽出物等の中から1種又は2種以上のも
のを選択し、この0.01〜1重量%を、及びヘスペリジン
又は酵素処理ヘスペリジンを0.005〜0.5重量%を添加す
れば、この飲料100mlを摂取するだけで、ケミカルメデ
ィエーター遊離抑制物質を10〜1,000mg、ヘスペリジン
又は酵素処理ヘスペリジンを5〜500mg摂取することがで
き、目的とする抗アレルギー効果を期待できる。以下に
実施例を示し、本発明をより詳細に説明する。
When a chemical mediator release-inhibiting substance and hesperidin or enzyme-treated hesperidin is added to a beverage, it should be added so as to exert an antiallergic effect with 100 ml of the beverage, in order to treat and manage the health of allergic patients. Highly convenient. For example, soft drinks, tea,
Fruit juices and milk drinks, etc., one or two or more kinds selected from the above-mentioned tea tea extract, rose petal extract, apple extract, perilla extract etc. as a chemical mediator release inhibitor, 0.01 ~ 1 wt%, and hesperidin or enzyme-treated hesperidin 0.005-0.5 wt%, by ingesting 100 ml of this beverage, chemical mediator release inhibitor 10-1,000 mg, hesperidin or enzyme-treated hesperidin 5 You can take up to 500mg, and expect the desired anti-allergic effect. Hereinafter, the present invention will be described in more detail with reference to Examples.

【0015】[0015]

【実施例1】表1に示す配合で原料を混合した後、140
℃で3秒間加熱殺菌し、紙パックに200mlずつ充填して、
抗アレルギー用飲食品である飲料を製造した。
Example 1 After mixing the raw materials in the composition shown in Table 1, 140
Heat sterilize at ℃ for 3 seconds, fill 200 ml each into a paper pack,
A beverage which is an antiallergic food and drink was produced.

【0016】[0016]

【表1】 [Table 1]

【0017】なお、この飲料200ml中には、甜茶抽出物
が固形量換算で300mg、酵素処理ヘスペリジンが30mg含
まれていた。
In addition, 200 ml of this beverage contained 300 mg of bean tea extract in terms of solid amount and 30 mg of enzyme-treated hesperidin.

【0018】[0018]

【実施例2】表2に示す配合で原料を混合した後、140
℃で3秒間加熱殺菌し、紙パックに200mlずつ充填して、
抗アレルギー用飲食品である飲料を製造した。
Example 2 After mixing the raw materials in the composition shown in Table 2, 140
Heat sterilize at ℃ for 3 seconds, fill 200 ml each into a paper pack,
A beverage which is an antiallergic food and drink was produced.

【0019】[0019]

【表2】 [Table 2]

【0020】なお、この飲料200ml中には、バラ花びら
抽出物が固形量換算で300mg、酵素処理ヘスペリジンが3
0mg含まれていた。
In 200 ml of this beverage, the rose petal extract was 300 mg in terms of solid amount, and the enzyme-treated hesperidin was 3 mg.
It contained 0 mg.

【0021】[0021]

【実施例3】上白糖70重量部と水飴(水分30%)25重量
部を、水蒸気で温度が140℃になるまで加熱しながら混
和、撹拌し、完全に溶解したことを確認した後、水道水
で100℃まで温度を下げ、甜茶抽出物(サントリー社
製)3重量部及び酵素処理ヘスペリジン(東洋精糖社
製)2重量部を加えて撹拌し、水道水で約60℃に温度を
下げて棒状に成形し、小判状に3gづつ打錠して、抗ア
レルギー用食品である飴を製造した。
[Example 3] 70 parts by weight of white sucrose and 25 parts by weight of starch syrup (water content 30%) were mixed with water vapor while heating until the temperature reached 140 ° C, stirred, and after confirming complete dissolution, tap water was added. The temperature is lowered to 100 ° C. with water, 3 parts by weight of the tea extract (manufactured by Suntory) and 2 parts by weight of enzyme-treated hesperidin (manufactured by Toyo Seika Co., Ltd.) are added and stirred, and the temperature is lowered to about 60 ° C. with tap water. It was molded into a rod shape and compressed into tablets of 3 g each to produce candy, which is an antiallergic food.

【0022】なお、この飴3g中には、甜茶抽出物が固形
量換算で90mg、酵素処理ヘスペリジンが60mg含まれてい
た。
3 g of this candy contained 90 mg of beetroot tea extract in terms of solid amount and 60 mg of enzyme-treated hesperidin.

【0023】[0023]

【実施例4】表3に示した配合でゼリーミックスを調製
し、分散溶解してから90℃まで湯煎で加熱した後、70℃
まで冷却した時点で、容器に100gずつ充填して冷却し、
抗アレルギー食品であるゼリーを製造した。
Example 4 A jelly mix having the composition shown in Table 3 was prepared, dispersed and dissolved, and then heated to 90 ° C. in a hot water bath, and then 70 ° C.
At the time of cooling to 100 g, fill each container and cool,
Jelly, an anti-allergic food, was manufactured.

【0024】[0024]

【表3】 [Table 3]

【0025】なお、このゼリー100g中には、甜茶抽出物
が固形量換算で150mg、酵素処理ヘスペリジンが15mg含
まれていた。
In 100 g of this jelly, 150 mg of beetroot tea extract and 15 mg of enzyme-treated hesperidin were included in terms of solid amount.

【0026】[0026]

【発明の効果】【The invention's effect】

【試験例1】本発明の効果を確認するために、ケミカル
メディエーター遊離抑制物質である甜茶抽出物と、酵素
処理ヘスペリジンについて、それぞれを単独で用いた場
合と、同時に用いた場合の抗アレルギー効果を調べた。
ddY系マウス(6週齢、雌、24匹)を、甜茶抽出物投与群
(A群)、酵素処理ヘスペリジン投与群(B群)、甜茶
抽出物及び酵素所処理ヘスペリジン投与群(C群)、対
照群(D群)に分け、A群には甜茶抽出物(サントリー
社製、サンテンチャ)25mgを水0.2mlに溶解したもの、
B群には酵素処理ヘスペリジン(東洋精糖社製)2.5mg
を水0.2mlに溶解したもの、C群には甜茶抽出物25mg及
び酵素処理ヘスペリジン(東洋精糖社製)2.5mgを水0.2
mlに溶解したもの、D群には水0.2mlを、1日1回、7
日間経口投与した。なお、7日目の投与は、アレルギー
反応惹起の1時間前に投与を行った。マウスは、投与5
日目に、両方の耳介にDNP特異的IgE抗体 62.5μg/mlを1
0μl皮内投与することで感作し、投与7日目に0.2mlの
0.25%エバンスブルー含有生理食塩水に溶解したDNP結
合ウシ血清アルブミン(DNP-BSA)0.05mgを静脈投与す
ることでアレルギー反応を惹起した。惹起30分後、耳介
に滲出したエバンスブルーを、1mlのホルムアミドで抽
出し、その濃度を620nmの吸光度で測定し、アレルギー
反応の強さとした。その結果を図1に示す。
[Test Example 1] In order to confirm the effect of the present invention, the antiallergic effect of the chemical extract, which is a chemical mediator release-inhibiting substance, and the enzyme-treated hesperidin were used alone and simultaneously. Examined.
ddY mice (6 weeks old, female, 24 mice) were treated with an extract of horse tea extract (group A), an enzyme-treated hesperidin administration group (group B), an extract of horse tea and an enzyme-treated hesperidin administration group (group C), Divided into a control group (D group), and in group A, 25 mg of beet extract extract (Suntencha, Suntencha) dissolved in 0.2 ml of water,
2.5 mg of enzyme-treated hesperidin (manufactured by Toyo Seito Co., Ltd.) for group B
Was dissolved in 0.2 ml of water, and for group C, 25 mg of beetroot tea extract and 2.5 mg of enzyme-treated hesperidin (manufactured by Toyo Seika Co., Ltd.) were added to water 0.2.
Dissolved in ml, 0.2 ml of water for group D once a day, 7
It was orally administered daily. The administration on the 7th day was performed 1 hour before the induction of the allergic reaction. Mice administered 5
On day 1, both ears received 12.5 μg / ml of DNP-specific IgE antibody 62.5 μg / ml.
Sensitization was carried out by intradermal administration of 0 μl, and 0.2 ml of
An allergic reaction was induced by intravenous administration of 0.05 mg of DNP-conjugated bovine serum albumin (DNP-BSA) dissolved in physiological saline containing 0.25% Evans blue. Thirty minutes after the induction, Evans blue exuded in the auricle was extracted with 1 ml of formamide, and the concentration was measured by the absorbance at 620 nm to determine the strength of the allergic reaction. The result is shown in FIG.

【0027】これによると、甜茶抽出物及び酵素処理ヘ
スペリジンを単独投与したA群及びB群では、対照であ
るD群との有意差は認められなかったが、甜茶抽出物と
酵素処理ヘスペリジンを投与したC群では、A、B及び
D群との有意差が認められた。このことは、甜茶抽出物
及び酵素処理ヘスペリジンの相乗効果により抗アレルギ
ー効果が増強されたことを示している。
According to this, in the groups A and B to which the black tea extract and the enzyme-treated hesperidin were administered alone, no significant difference was observed from the control group D, but the black tea extract and the enzyme-treated hesperidin were administered. In the C group, the significant difference from the A, B and D groups was observed. This indicates that the antiallergic effect was enhanced by the synergistic effect of the beet extract and the enzyme-treated hesperidin.

【0028】[0028]

【試験例2】試験例1で用いたddy系マウスのかわりにW
ister系ラット(6週令、雄)を用いて、1群を5匹とし、
甜茶抽出物及び酵素処理ヘスペリジンの投与量をそれぞ
れ100mg/1ml、10mg/1mlとした以外は、同様にして11日
間投与した。最終投与の1時間後に、剃毛した背部にDNP
特異的IgE抗体 62.5μg/mlを50μl皮内投与することで
感作し、18時間後に1mlの0.5%エバンスブルー含有生理
食塩水に溶解したDNP-BSA 1mgを静脈投与することでア
レルギー反応を惹起した。惹起30分後、背部皮内の感作
した部分に滲出したエバンスブルーを、5mlのホルムア
ミドで抽出し、その濃度を620nmの吸光度で測定し、ア
レルギー反応の強さとした。その結果を図2に示す。
[Test Example 2] W instead of the ddy mouse used in Test Example 1
Using sister rats (6 weeks old, male), one group has 5 animals,
Administration was carried out for 11 days in the same manner except that the doses of beetroot extract and enzyme-treated hesperidin were 100 mg / 1 ml and 10 mg / 1 ml, respectively. One hour after the final administration, DNP was applied to the shaved back.
Sensitization was carried out by intradermal administration of 50 μl of 62.5 μg / ml specific IgE antibody, and after 18 hours, 1 mg of DNP-BSA dissolved in 1 ml of physiological saline containing 0.5% Evans blue was intravenously administered to induce an allergic reaction. did. Thirty minutes after the induction, Evans blue exuded in the sensitized part of the back skin was extracted with 5 ml of formamide, and the concentration was measured by the absorbance at 620 nm to determine the strength of the allergic reaction. The result is shown in FIG.

【0029】これによると、甜茶抽出物及び酵素処理ヘ
スペリジンを単独投与したA群及びB群、甜茶抽出物と
酵素処理ヘスペリジンを混合して投与したC群は、対照
であるD群との有意差が認められた。さらにC群は、A
群及びB群との有意差が認められた。このことは、甜茶
抽出物及び酵素処理ヘスペリジンの相乗効果により抗ア
レルギー効果が増強されたことを示している。
According to this, the groups A and B to which the tea extract and the enzyme-treated hesperidin were administered alone, and the group C to which the tea extract and the enzyme-treated hesperidin were mixed and administered were significantly different from the control group D. Was recognized. Furthermore, C group is A
A significant difference was observed between the groups and group B. This indicates that the antiallergic effect was enhanced by the synergistic effect of the beet extract and the enzyme-treated hesperidin.

【0030】以上の試験結果から、ケミカルメディエー
ター遊離を抑制する成分に加えて、ヘスペリジンを同時
に配合することで、実際のアレルギー症状をより効果的
に軽減させることが可能であることが確認された。従っ
て、本発明の実施により、有効な抗アレルギー用飲食品
が提供される。
From the above test results, it was confirmed that the actual allergic symptom can be more effectively reduced by simultaneously adding hesperidin in addition to the component for suppressing the release of the chemical mediator. Therefore, the practice of the present invention provides an effective antiallergic food and drink.

【0031】[0031]

【図面の簡単な説明】[Brief description of drawings]

【図1】甜茶抽出物と酵素処理ヘスペリジンのマウス耳
介におけるアレルギー反応の抑制効果を示す。
FIG. 1 shows the inhibitory effect of the beet extract and enzyme-treated hesperidin on allergic reactions in mouse auricles.

【図2】甜茶抽出物と酵素処理ヘスペリジンのラット背
部皮内におけるアレルギー反応の抑制効果を示す。
FIG. 2 shows the inhibitory effect of the beet extract and enzyme-treated hesperidin on the allergic reaction in the dorsal skin of rats.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 31/352 A61K 35/78 C 4C084 35/78 H 4C086 K 4C088 Q 45/00 45/00 A61P 37/08 A61P 37/08 A23G 3/00 101 // A23G 3/00 101 A23L 1/06 A23L 1/06 2/00 F Fターム(参考) 4B014 GB06 GG09 GK12 GL03 4B016 LC07 LG01 LG02 LG05 LG16 LK02 LP02 4B017 LC03 LG01 LG02 LG14 LG15 LK06 LK16 LL09 LP01 LP06 4B018 LB01 LB08 MD07 MD23 MD52 MD59 MD61 ME07 MF01 MF12 4B041 LC10 LD01 LK05 LK27 LK29 LK32 LP05 4C084 AA19 MA02 MA16 MA52 NA14 ZB131 4C086 AA01 AA02 BA08 MA02 MA04 MA16 MA52 NA14 ZB13 4C088 AB12 AB38 AB45 AB51 AB62 CA03 MA16 MA52 NA14 ZB13─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. 7 Identification code FI theme code (reference) A61K 31/352 A61K 35/78 C 4C084 35/78 H 4C086 K 4C088 Q 45/00 45/00 A61P 37 / 08 A61P 37/08 A23G 3/00 101 // A23G 3/00 101 A23L 1/06 A23L 1/06 2/00 FF term (reference) 4B014 GB06 GG09 GK12 GL03 4B016 LC07 LG01 LG02 LG05 LG16 LK02 LP02 4B017 LC03 LG01 LG02 LG14 LG15 LK06 LK16 LL09 LP01 LP06 4B018 LB01 LB08 MD07 MD23 MD52 MD59 MD61 ME07 MF01 MF12 4B041 LC10 LD01 LK05 LK27 LK29 LK32 LP05 4C084 AA19 MA02 MA16 MA52 MA16 MA52 NA14 ZB131 4C086 AA52 MA14 MA08 MAAMA NAA02 MA14 MA04 MA08 MAB02 MA08 MAB02 MA04 MA08 MAA02 CA03 MA16 MA52 NA14 ZB13

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】ケミカルメディエーター遊離抑制物質とヘ
スペリジン及び/又は酵素処理ヘスペリジンを含有する
抗アレルギー用飲食品。
1. An antiallergic food or drink containing a chemical mediator release inhibitor and hesperidin and / or enzyme-treated hesperidin.
【請求項2】ヘスペリジン及び/又は酵素処理ヘスペリ
ジンが柑橘類から抽出されたものである請求項1記載の
抗アレルギー用飲食品。
2. The anti-allergic food and drink according to claim 1, wherein hesperidin and / or enzyme-treated hesperidin is extracted from citrus fruits.
【請求項3】柑橘類がレモン、オレンジ、グレープフル
ーツ、ミカン、キンカン、カラタチ、ユズの中から選ば
れる1種または2種以上である請求項2記載の抗アレル
ギー用飲食品。
3. The antiallergic food or drink according to claim 2, wherein the citrus fruits are one or more selected from lemon, orange, grapefruit, mandarin orange, kumquat, zelkova and yuzu.
【請求項4】ケミカルメディエーター遊離抑制物質が甜
茶抽出物、バラ花びら抽出物、リンゴ抽出物、シソ抽出
物から選ばれる1種又は2種以上である請求項1〜3の
何れかに記載の抗アレルギー用飲食品。
4. The anti-oxidant according to any one of claims 1 to 3, wherein the chemical mediator release inhibiting substance is one kind or two or more kinds selected from a tea extract, a rose petal extract, an apple extract and a perilla extract. Food and drink for allergies.
【請求項5】甜茶抽出物を0.01〜1重量%、ヘスペリジ
ン及び/又は酵素処理ヘスペリジンを0.005〜0.5重量%
含有する抗アレルギー用飲食品。
5. The tea extract is 0.01 to 1% by weight, and hesperidin and / or enzyme-treated hesperidin is 0.005 to 0.5% by weight.
Foods and drinks for anti-allergic products.
JP2001374099A 2001-12-07 2001-12-07 Antiallergic agent Expired - Fee Related JP4524465B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001374099A JP4524465B2 (en) 2001-12-07 2001-12-07 Antiallergic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001374099A JP4524465B2 (en) 2001-12-07 2001-12-07 Antiallergic agent

Publications (2)

Publication Number Publication Date
JP2003169631A true JP2003169631A (en) 2003-06-17
JP4524465B2 JP4524465B2 (en) 2010-08-18

Family

ID=19182710

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001374099A Expired - Fee Related JP4524465B2 (en) 2001-12-07 2001-12-07 Antiallergic agent

Country Status (1)

Country Link
JP (1) JP4524465B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005104847A (en) * 2003-09-26 2005-04-21 Fumakilla Ltd Allergen remover
JP2005179308A (en) * 2003-12-22 2005-07-07 Oriza Yuka Kk Antiallergy composition
JP2005343865A (en) * 2004-06-07 2005-12-15 Toyo Seito Kk Low smelling enzyme-treated hesperidin composition
JP2007063221A (en) * 2005-09-01 2007-03-15 Pokka Corp Insulin resistance improving agent, hypoglycemic agent and diabetes prevention agent
CN101247734B (en) * 2005-07-27 2012-03-21 西姆莱斯有限责任两合公司 Use of hesperetin for enhancing the sweet taste
JP5153948B1 (en) * 2012-03-09 2013-02-27 株式会社オーエーハウジング設計 Allergic rhinitis coating agent
US9688712B2 (en) 2010-06-09 2017-06-27 Kao Corporation Manufacturing method for polyphenol composition

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04295428A (en) * 1991-03-22 1992-10-20 Dai Ichi Seiyaku Co Ltd Antiallergic agent
JPH08188593A (en) * 1995-01-10 1996-07-23 Wakayama Agribio Kenkyu Center:Kk Extraction and recovery of hesperidin contained in citrus fruits
JPH0920672A (en) * 1995-07-04 1997-01-21 Agency Of Ind Science & Technol Antiallergic substance, its production, antiallergic agent and functional food
JPH09118626A (en) * 1996-09-20 1997-05-06 Suntory Ltd Medicine containing 'tencha' extract as active ingredient and food product and cosmetic containing the same
JPH10287525A (en) * 1997-02-11 1998-10-27 Pure:Kk Cosmetic, food and bathing agent
JPH1156297A (en) * 1997-08-21 1999-03-02 Fuankeru:Kk Antiallergic food
JPH11100325A (en) * 1997-07-31 1999-04-13 Hayashibara Biochem Lab Inc Composition
JPH11318379A (en) * 1998-05-15 1999-11-24 Tanabe Seiyaku Co Ltd Improvement in flavor of food or beverage, and agent for improving flavor
JP2000236848A (en) * 1998-12-02 2000-09-05 Kanebo Ltd Beta-hexosaminidase liberation inhibitor and antiinflammatory food containing the same
JP2003501343A (en) * 1998-10-20 2003-01-14 コリア インスティテュート オブ サイエンス アンド テクノロジー Bioflavonoids for increasing serum high density lipoprotein concentration

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04295428A (en) * 1991-03-22 1992-10-20 Dai Ichi Seiyaku Co Ltd Antiallergic agent
JPH08188593A (en) * 1995-01-10 1996-07-23 Wakayama Agribio Kenkyu Center:Kk Extraction and recovery of hesperidin contained in citrus fruits
JPH0920672A (en) * 1995-07-04 1997-01-21 Agency Of Ind Science & Technol Antiallergic substance, its production, antiallergic agent and functional food
JPH09118626A (en) * 1996-09-20 1997-05-06 Suntory Ltd Medicine containing 'tencha' extract as active ingredient and food product and cosmetic containing the same
JPH10287525A (en) * 1997-02-11 1998-10-27 Pure:Kk Cosmetic, food and bathing agent
JPH11100325A (en) * 1997-07-31 1999-04-13 Hayashibara Biochem Lab Inc Composition
JPH1156297A (en) * 1997-08-21 1999-03-02 Fuankeru:Kk Antiallergic food
JPH11318379A (en) * 1998-05-15 1999-11-24 Tanabe Seiyaku Co Ltd Improvement in flavor of food or beverage, and agent for improving flavor
JP2003501343A (en) * 1998-10-20 2003-01-14 コリア インスティテュート オブ サイエンス アンド テクノロジー Bioflavonoids for increasing serum high density lipoprotein concentration
JP2000236848A (en) * 1998-12-02 2000-09-05 Kanebo Ltd Beta-hexosaminidase liberation inhibitor and antiinflammatory food containing the same

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
日経流通新聞, JPNX007000189, 1996, pages 6, ISSN: 0000808349 *
杉靖三郎 監修, 健康・栄養食品事典, JPNX007000187, 1996, pages 379, ISSN: 0000808347 *
産経新聞 東京朝刊, JPNX007000188, 17 November 1999 (1999-11-17), pages 18, ISSN: 0000808348 *
秋田秀秋, 薬学雑誌, vol. Vol. 111(3), JPN4006010026, 1991, pages 193 - 198, ISSN: 0000745509 *
秋田秀秋, 薬学雑誌, vol. Vol. 111(3), JPNX007000186, 1991, pages 193 - 198, ISSN: 0000808346 *
秋田秀秋, 薬学雑誌, vol. Vol. 111(3), JPNX007028598, 1991, pages 193 - 198, ISSN: 0000858619 *
食品と科学, vol. Vol. 41(2), JPN4007000135, 1999, pages 90 - 94, ISSN: 0000808344 *
食品と科学, vol. Vol. 41(2), JPNX007028600, 1999, pages 90 - 94, ISSN: 0000858621 *
食品と開発, vol. Vol. 32(2), JPN4007000134, 1997, pages 22 - 24, ISSN: 0000808343 *
食品と開発, vol. Vol. 32(2), JPNX007028599, 1997, pages 22 - 24, ISSN: 0000858620 *
高木敬次郎 他 編著, 薬物学, JPN4007000136, 1984, pages 18 - 19, ISSN: 0000808345 *
高木敬次郎 他 編著, 薬物学, JPNX007028601, 1984, pages 18 - 19, ISSN: 0000858622 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005104847A (en) * 2003-09-26 2005-04-21 Fumakilla Ltd Allergen remover
JP2005179308A (en) * 2003-12-22 2005-07-07 Oriza Yuka Kk Antiallergy composition
JP2005343865A (en) * 2004-06-07 2005-12-15 Toyo Seito Kk Low smelling enzyme-treated hesperidin composition
JP4731835B2 (en) * 2004-06-07 2011-07-27 東洋精糖株式会社 Low odor enzyme treated hesperidin composition
CN101247734B (en) * 2005-07-27 2012-03-21 西姆莱斯有限责任两合公司 Use of hesperetin for enhancing the sweet taste
US8679461B2 (en) 2005-07-27 2014-03-25 Symrise Ag Use of hesperetin for enhancing the sweet taste
JP2007063221A (en) * 2005-09-01 2007-03-15 Pokka Corp Insulin resistance improving agent, hypoglycemic agent and diabetes prevention agent
US9688712B2 (en) 2010-06-09 2017-06-27 Kao Corporation Manufacturing method for polyphenol composition
JP5153948B1 (en) * 2012-03-09 2013-02-27 株式会社オーエーハウジング設計 Allergic rhinitis coating agent
WO2013133062A1 (en) * 2012-03-09 2013-09-12 株式会社オーエーハウジング設計 Coating agent for allergic rhinitis

Also Published As

Publication number Publication date
JP4524465B2 (en) 2010-08-18

Similar Documents

Publication Publication Date Title
CA2624929C (en) Antiobesity composition
RU2317821C2 (en) Composition containing actinidia arguta extract (sharp actinidia) and plants of related genus for prophylaxis and treatment of allergic diseases and non-allergic inflammatory diseases
KR20080030633A (en) Method of treatment or management of stress
US8142823B2 (en) Nutraceutical composition
Uhegbu et al. Effect of aqueous extract of Piper guineense seeds on some liver enzymes, antioxidant enzymes and some hematological parameters in albino rats
CN112450337B (en) Preparation method of charcoal-roasted milk beverage with antioxidant function from extract of Piteguo and astragalus membranaceus
JP2003169631A (en) Anti-allergic drink or food
CN104397542A (en) Millet-radix polygoni multiflori porridge
EP1637149A1 (en) Dietary supplement composition for the man
US8895083B2 (en) Composition for the maintenance of blood sugar levels comprising cinnamon and ginseng
KR101690369B1 (en) Anti-obesity composition containing bitter melon mixture hot water extract and manufacturing method thereof
KR102092787B1 (en) A pill for functional food comprising Protaetia brevitarsis seulensis and manufacturing method therof
CN109452417A (en) A kind of pure natural fat eliminating Weight reducing tea drink and preparation method thereof
Ashok et al. Nutraceutical values of minor fruits on immunity development to combat diseases
JP2022124984A (en) Lipase activity inhibitor and use thereof
JP7122727B2 (en) Beverage containing ferulic acid
KR101060325B1 (en) Health supplement food with improved property of liver function and recovering fatigue and making method thereof
JP2006213608A (en) Antidepressant and use of the same
JP2001046019A (en) Nutritive composition originated from citrus fruit
CN104473283A (en) Rose-ginger vinegar beverage and preparation method thereof
JP2005053786A (en) Food and drink comprising extract derived from citrus pericarp and having inhibitory action on blood pressure rise
JP7072930B2 (en) Ferulic acid-containing beverage
JP7474432B2 (en) Antiallergic
TW200528123A (en) Lipase inhibitor
JP2003238434A (en) Hyaluronidase activity inhibitor, food and beverage and cosmetic containing the same

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040914

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20051014

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060613

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060814

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20060814

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070109

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070309

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070530

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100514

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130611

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 4524465

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060814

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130611

Year of fee payment: 3

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130611

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130611

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees